Daiwa Securities Group Inc. Wave Life Sciences Ltd. Transaction History
Daiwa Securities Group Inc.
- $21.6 Billion
- Q3 2024
A detailed history of Daiwa Securities Group Inc. transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 349 shares of WVE stock, worth $5,235. This represents 0.0% of its overall portfolio holdings.
Number of Shares
349
Previous 349
-0.0%
Holding current value
$5,235
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding WVE
# of Institutions
164Shares Held
116MCall Options Held
148KPut Options Held
109K-
Ra Capital Management, L.P. Boston, MA18.2MShares$273 Million2.08% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx10MShares$151 Million1.71% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.7MShares$146 Million0.15% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$101 Million0.0% of portfolio
-
M28 Capital Management LP Stamford, CT6.16MShares$92.5 Million48.05% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $1.3B
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...